← Leaderboards
Edward Sander Connolly
Columbia University Health Sciences
$9,326,629
Attributed
$14,923,305
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2007–25$2.5M$1.9M$1.3M$625K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,792,713 · 6
AHRQ$2,436,134 · 1
FDA$694,458 · 1
By mechanism
R01$11,916,735 · 5
U24$2,717,393 · 1
S10$176,290 · 1
K08$112,887 · 1
Top collaborators
- Randolph S Marshall13 shared
- Philip Stieg8 shared
- Dana Leifer7 shared
- Matthew Fink6 shared
- Ronald M Lazar5 shared
- David Sigmund Liebeskind5 shared
- Eric John Heyer2 shared
- Babak Benjamin Navi1 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Randolph S Marshall$10,866,382
- Philip Stieg$589,926
- Eric John Heyer$4,690,953
- Ralph Lewis Sacco$56,271,933
- Dana Leifer$482,711
Others in their field
Top investigators on “Stroke”
- Judith S Hochman · New York University School Of Medicine$100,533,713
- Joseph Paul Broderick · University Of Cincinnati$91,227,021
- Merit E Cudkowicz · Massachusetts General Hospital$58,780,575
- Paul M. Ridker · Brigham And Women'S Hospital$56,179,451
- Marinella Temprosa · George Washington University$56,125,420
- Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai$53,611,126
Research focus
StrokeCarotid StenosisCognitionEnrollmentDisabilityFundingClinical TrialsCerebral HemodynamicsRecoveryProgramsSideFailureAcuteAncillary StudyStroke PreventionUnited States National Institutes Of HealthMortalityPhagocytosisPhase Iii Clinical TrialsDemographicsAdultInnovationAdmission ActivityCryptogenic Stroke
Grant awards (34)
Stroke Trials Network of Columbia and Cornell$428,858
U24 · FY2025 · NS
Stroke Trials Network of Columbia and Cornell$500,083
U24 · FY2024 · NS
Stroke Trials Network of Columbia and Cornell$186,392
U24 · FY2023 · NS
Stroke Trials Network of Columbia and Cornell$311,804
U24 · FY2022 · NS
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics (CREST-H)$614,629
R01 · FY2021 · NS
Stroke Trials Network of Columbia and Cornell$316,807
U24 · FY2021 · NS
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics (CREST-H)$617,741
R01 · FY2020 · NS
Stroke Trials Network of Columbia and Cornell$314,615
U24 · FY2020 · NS
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics (CREST-H)$622,387
R01 · FY2019 · NS
Stroke Trials Network of Columbia and Cornell$319,095
U24 · FY2019 · NS
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics (CREST-H)$625,320
R01 · FY2018 · NS
Topical Vancomycin for Craniotomy Wound Prophylaxis$452,414
R01 · FY2018 · HS · contact PI
Stroke Trials Network of Columbia and Cornell$339,739
U24 · FY2018 · NS
Statin Neuroprotection & Cognitive Dysfunction after Carotid Endarterectomy: Safety, Feasibility, & Outcomes.$973,557
R01 · FY2017 · AG · contact PI
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics (CREST-H)$714,544
R01 · FY2017 · NS
Topical Vancomycin for Craniotomy Wound Prophylaxis$498,820
R01 · FY2017 · HS · contact PI
Statin Neuroprotection & Cognitive Dysfunction after Carotid Endarterectomy: Safety, Feasibility, & Outcomes.$1,172,928
R01 · FY2016 · AG · contact PI
Topical Vancomycin for Craniotomy Wound Prophylaxis$498,820
R01 · FY2016 · HS · contact PI
Topical Vancomycin for Craniotomy Wound Prophylaxis$498,820
R01 · FY2015 · HS · contact PI
Topical Vancomycin for Craniotomy Wound Prophylaxis$487,260
R01 · FY2014 · HS · contact PI
Phase II Trial of Tiopronin in Aneurysmal Subarachnoid Hemorrhage$219,433
R01 · FY2011 · FD · contact PI
COMPLEMENT-MEDIATED NEURONAL INJURY IN STROKE$349,050
R01 · FY2010 · NS · contact PI
Phase II Trial of Tiopronin in Aneurysmal Subarachnoid Hemorrhage$226,320
R01 · FY2010 · FD · contact PI
COMPLEMENT-MEDIATED NEURONAL INJURY IN STROKE$386,042
R01 · FY2009 · NS · contact PI
Phase II Trial of Tiopronin in Aneurysmal Subarachnoid Hemorrhage$248,705
R01 · FY2009 · FD · contact PI
COMPLEMENT-MEDIATED NEURONAL INJURY IN STROKE$380,096
R01 · FY2008 · NS · contact PI
COMPLEMENT-MEDIATED NEURONAL INJURY IN STROKE$363,344
R01 · FY2007 · NS · contact PI
COMPLEMENT-MEDIATED NEURONAL INJURY IN STROKE$389,776
R01 · FY2004 · NS
COMPLEMENT-MEDIATED NEURONAL INJURY IN STROKE$389,776
R01 · FY2003 · NS
OEC 9800 C-ARM - DIGITAL MOBILE IMAGING SYSTEM$176,290
S10 · FY2003 · RR
COMPLEMENT-MEDIATED NEURONAL INJURY IN STROKE$389,776
R01 · FY2002 · NS
COMPLEMENT-MEDIATED NEURONAL INJURY IN STROKE$389,776
R01 · FY2001 · NS
COMPLEMENT-MEDIATED NEURONAL INJURY IN STROKE$407,401
R01 · FY2000 · NS
MICROVASCULAR FAILURE IN MURINE AND PRIMATE STROKE$112,887
K08 · FY2000 · NS